Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method

Int J Antimicrob Agents. 2012 Nov;40(5):416-22. doi: 10.1016/j.ijantimicag.2012.06.022. Epub 2012 Aug 10.

Abstract

There is an increasing interest in monitoring plasma concentrations of β-lactam antibiotics. The objective of this work was to develop and validate a rapid ultra-performance liquid chromatographic method with tandem mass spectrometric detection (UPLC-MS/MS) for simultaneous quantification of amoxicillin, ampicillin, cefuroxime, cefazolin, ceftazidime, meropenem, piperacillin, clavulanic acid and tazobactam. Sample clean-up included protein precipitation with acetonitrile and back-extraction of acetonitrile with dichloromethane. Six deuterated β-lactam antibiotics were used as internal standards. Chromatographic separation was performed on a Waters ACQUITY UPLC system using a BEH C(18) column (1.7 μm, 100 mm×2.1 mm) applying a binary gradient elution of water and acetonitrile both containing 0.1% formic acid. The total run time was 5.5 min. The developed method was validated in terms of precision, accuracy, linearity, matrix effect and recovery. The assay has now been successfully used to determine concentrations of amoxicillin/clavulanic acid, cefuroxime and meropenem in plasma samples from intensive care patients.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / blood*
  • Chromatography, Liquid / methods*
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / blood*
  • Human Experimentation
  • Humans
  • Plasma / chemistry*
  • Tandem Mass Spectrometry / methods*
  • beta-Lactams / administration & dosage
  • beta-Lactams / blood*

Substances

  • Anti-Bacterial Agents
  • Enzyme Inhibitors
  • beta-Lactams